Skip to main content
Journal cover image

ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging.

Publication ,  Journal Article
Expert Panel on Urologic Imaging:, ; Coakley, FV; Oto, A; Alexander, LF; Allen, BC; Davis, BJ; Froemming, AT; Fulgham, PF; Hosseinzadeh, K ...
Published in: J Am Coll Radiol
May 2017

Despite the frequent statement that "most men die with prostate cancer, not of it," the reality is that prostate cancer is second only to lung cancer as a cause of death from malignancy in American men. The primary goal during baseline evaluation of prostate cancer is disease characterization, that is, establishing disease presence, extent (local and distant), and aggressiveness. Prostate cancer is usually diagnosed after the finding of a suspicious serum prostate-specific antigen level or digital rectal examination. Tissue diagnosis may be obtained by transrectal ultrasound-guided biopsy or MRI-targeted biopsy. The latter requires a preliminary multiparametric MRI, which has emerged as a powerful and relatively accurate tool for the local evaluation of prostate cancer over the last few decades. Bone scintigraphy and CT are primarily used to detect bone and nodal metastases in patients found to have intermediate- or high-risk disease at biopsy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

May 2017

Volume

14

Issue

5S

Start / End Page

S245 / S257

Location

United States

Related Subject Headings

  • United States
  • Ultrasonography, Interventional
  • Societies, Medical
  • Radiology
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Male
  • Magnetic Resonance Imaging, Interventional
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Expert Panel on Urologic Imaging:, ., Coakley, F. V., Oto, A., Alexander, L. F., Allen, B. C., Davis, B. J., … Eberhardt, S. C. (2017). ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol, 14(5S), S245–S257. https://doi.org/10.1016/j.jacr.2017.02.026
Expert Panel on Urologic Imaging:, Steven C., Fergus V. Coakley, Aytekin Oto, Lauren F. Alexander, Brian C. Allen, Brian J. Davis, Adam T. Froemming, et al. “ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging.J Am Coll Radiol 14, no. 5S (May 2017): S245–57. https://doi.org/10.1016/j.jacr.2017.02.026.
Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, et al. ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol. 2017 May;14(5S):S245–57.
Expert Panel on Urologic Imaging:, Steven C., et al. “ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging.J Am Coll Radiol, vol. 14, no. 5S, May 2017, pp. S245–57. Pubmed, doi:10.1016/j.jacr.2017.02.026.
Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol. 2017 May;14(5S):S245–S257.
Journal cover image

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

May 2017

Volume

14

Issue

5S

Start / End Page

S245 / S257

Location

United States

Related Subject Headings

  • United States
  • Ultrasonography, Interventional
  • Societies, Medical
  • Radiology
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Male
  • Magnetic Resonance Imaging, Interventional